JP2009531403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009531403A5 JP2009531403A5 JP2009502205A JP2009502205A JP2009531403A5 JP 2009531403 A5 JP2009531403 A5 JP 2009531403A5 JP 2009502205 A JP2009502205 A JP 2009502205A JP 2009502205 A JP2009502205 A JP 2009502205A JP 2009531403 A5 JP2009531403 A5 JP 2009531403A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- independently
- nme
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 42
- 238000000034 method Methods 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- 208000034799 Tauopathies Diseases 0.000 claims 4
- 241000710886 West Nile virus Species 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 230000004845 protein aggregation Effects 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 241000711549 Hepacivirus C Species 0.000 claims 2
- 241000725303 Human immunodeficiency virus Species 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 208000030381 cutaneous melanoma Diseases 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 201000004792 malaria Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 230000000626 neurodegenerative effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000000849 skin cancer Diseases 0.000 claims 2
- 201000003708 skin melanoma Diseases 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 150000007518 monoprotic acids Chemical class 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78669006P | 2006-03-29 | 2006-03-29 | |
| US60/786,690 | 2006-03-29 | ||
| PCT/GB2007/001103 WO2007110627A2 (en) | 2006-03-29 | 2007-03-28 | 3,7-diamino-10h-phenothiazine salts and their use |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013026635A Division JP5814957B2 (ja) | 2006-03-29 | 2013-02-14 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
| JP2013236080A Division JP2014055165A (ja) | 2006-03-29 | 2013-11-14 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009531403A JP2009531403A (ja) | 2009-09-03 |
| JP2009531403A5 true JP2009531403A5 (https=) | 2010-04-30 |
| JP5520043B2 JP5520043B2 (ja) | 2014-06-11 |
Family
ID=38421429
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502205A Active JP5520043B2 (ja) | 2006-03-29 | 2007-03-28 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
| JP2013026635A Active JP5814957B2 (ja) | 2006-03-29 | 2013-02-14 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
| JP2013236080A Pending JP2014055165A (ja) | 2006-03-29 | 2013-11-14 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013026635A Active JP5814957B2 (ja) | 2006-03-29 | 2013-02-14 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
| JP2013236080A Pending JP2014055165A (ja) | 2006-03-29 | 2013-11-14 | ３，７−ジアミノ−１０ｈ−フェノチアジン塩およびその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US7888350B2 (https=) |
| EP (1) | EP2013191B3 (https=) |
| JP (3) | JP5520043B2 (https=) |
| KR (1) | KR100983301B1 (https=) |
| CN (5) | CN101460472B (https=) |
| AT (1) | ATE478058T3 (https=) |
| AU (1) | AU2007231124B2 (https=) |
| CA (1) | CA2646163C (https=) |
| DE (1) | DE602007008550D1 (https=) |
| DK (1) | DK2013191T6 (https=) |
| EA (1) | EA014552B1 (https=) |
| ES (1) | ES2349322T7 (https=) |
| HR (1) | HRP20100614T4 (https=) |
| IL (2) | IL194516A (https=) |
| MY (1) | MY143757A (https=) |
| PL (1) | PL2013191T6 (https=) |
| PT (1) | PT2013191E (https=) |
| WO (1) | WO2007110627A2 (https=) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101084204B (zh) | 2004-09-23 | 2012-12-05 | 卫思道制药有限公司 | 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法 |
| ES2349322T7 (es) * | 2006-03-29 | 2019-10-17 | Wista Lab Ltd | Sales de 3,7-diamino-10H-fenotiazina y su utilización |
| SI2004155T1 (en) | 2006-03-29 | 2018-05-31 | Wista Laboratories Ltd. | Inhibitors of protein aggregation |
| MY148145A (en) | 2006-07-11 | 2013-03-15 | Wista Lab Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| US8227459B2 (en) * | 2007-04-03 | 2012-07-24 | Prosetta Antiviral Inc. | Diamino-phenothiazinyl derivatives as antiviral treatments |
| AU2008265045B2 (en) * | 2007-06-19 | 2014-02-27 | Taurx Therapeutics Management Ltd. | Phenothiazine compounds for treating Mild Cognitive Impairment |
| FR2920775B1 (fr) | 2007-09-07 | 2009-11-06 | Pharma Hydro Dev P H D Soc Par | Nouveaux composes diaminophenothiazine, leur procede de preparation et leurs utilisations. |
| CA2701075C (en) * | 2007-10-03 | 2019-02-12 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines. |
| PL3689346T3 (pl) | 2008-12-10 | 2024-06-24 | Wista Laboratories Ltd. | 3,6-Dipodstawione sole ksantyliowe do leczenia tauopatii |
| JP5918136B2 (ja) * | 2009-09-24 | 2016-05-18 | ウィスタ ラボラトリーズ リミテッド | プロセス |
| MX355627B (es) * | 2009-09-24 | 2018-04-25 | Wista Lab Ltd | Clorhidratos de metiltioninio (azul de metileno) cristalinos. |
| JP5868955B2 (ja) | 2010-04-30 | 2016-02-24 | プロセッタ アンチバイラル インコーポレイテッド | 抗ウイルス化合物 |
| JP6093707B2 (ja) | 2010-11-30 | 2017-03-08 | ウィスタ ラボラトリーズ リミテッド | 化合物製剤 |
| US20120244174A1 (en) | 2011-01-31 | 2012-09-27 | Intellect Neurosciences Inc. | Treatment of tauopathies |
| JP5898701B2 (ja) * | 2011-02-11 | 2016-04-13 | ウィスタ ラボラトリーズ リミテッド | フェノチアジンジアミニウム塩およびそれらの使用 |
| EP2699241B1 (en) | 2011-04-20 | 2016-07-27 | Prosetta Antiviral Inc. | Antiviral compounds |
| US20130315825A1 (en) * | 2012-05-03 | 2013-11-28 | Washington University | Tricyclic heteroaromatic compounds as alpha-synuclein ligands |
| GB201512678D0 (en) * | 2015-07-20 | 2015-08-26 | Wista Lab Ltd | Methods of chemical synthesis |
| CN105541756B (zh) * | 2015-12-17 | 2018-02-09 | 陕西方舟制药有限公司 | 一种制备1‑(3，7‑双二甲氨基‑吩噻嗪‑10‑基)乙酮的方法 |
| ITUA20163526A1 (it) * | 2016-05-17 | 2017-11-17 | Icrom Spa | Procedimento per la preparazione di composti diamminofenotiazinici ad elevato grado di purezza |
| JP7073330B2 (ja) * | 2016-07-25 | 2022-05-23 | ウィスタ ラボラトリーズ リミテッド | ジアミノフェノチアジンの投与及び投与量 |
| GB201614834D0 (en) * | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| GB201621817D0 (en) * | 2016-12-21 | 2017-02-01 | Wista Lab Ltd | Methods of chemical synthesis |
| CN107253936B (zh) * | 2017-06-23 | 2021-07-23 | 复旦大学 | 一类可用于次氯酸检测的荧光探针及其制备方法和应用 |
| CN108129418A (zh) * | 2017-12-22 | 2018-06-08 | 郑州大学 | 吩噻嗪-氨基二硫代甲酸酯衍生物及其制备方法和应用 |
| FI4385512T3 (fi) | 2018-07-26 | 2026-01-12 | Taurx Therapeutics Man Ltd | Diaminofenotiatsiinien optimoitu annostus populaatioille |
| EP3847664A1 (en) | 2018-09-05 | 2021-07-14 | Genting Taurx Diagnostic Centre SDN BHD | Network methods for neurodegenerative diseases |
| CN109223800A (zh) * | 2018-10-26 | 2019-01-18 | 辽宁大学 | 3,7-二对甲苯胺基-吩噻嗪-5-鎓碘化物与超声协同在抑制肿瘤细胞增殖中的应用 |
| WO2020201828A1 (en) | 2019-04-05 | 2020-10-08 | Tauc3 Biologics Limited | Anti-tauc3 antibodies and uses thereof |
| GB201909493D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
| GB201909454D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Enhancers |
| GB201909506D0 (en) | 2019-07-02 | 2019-08-14 | Wista Lab Ltd | Synaptopathies |
| GB202006659D0 (en) | 2020-05-05 | 2020-06-17 | Wista Lab Ltd | Therapeutic treatments |
| KR20230012514A (ko) | 2020-05-05 | 2023-01-26 | 위스타 레보레이토리스 리미티드 | 치료방법 |
| MX2022013884A (es) * | 2020-05-05 | 2022-11-30 | Wista Lab Ltd | Compuestos de metiltioninio para usarse en el tratamiento de hipoxemia. |
| GB202010652D0 (en) | 2020-07-10 | 2020-08-26 | Wista Lab Ltd | Anti-tau antibodies |
| DE102020212508A1 (de) | 2020-10-02 | 2022-04-07 | Continental Reifen Deutschland Gmbh | Verbindung, Kautschukmischung enthaltend die Verbindung, Fahrzeugreifen, der die Kautschukmischung in wenigstens einem Bauteil aufweist, Verfahren zur Herstellung der Verbindung sowie Verwendung der Verbindung als Alterungsschutzmittel und/oder Antioxidationsmittel und/oder Antiozonant und/oder Farbstoff |
| GB202204185D0 (en) | 2022-03-24 | 2022-05-11 | Wista Lab Ltd | Oral treatment |
| AU2023279800A1 (en) | 2022-05-31 | 2024-12-19 | TauRx Therapeutics Management Ltd | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
| EP4590306A1 (en) | 2022-09-21 | 2025-07-30 | Yin Sze Loh | Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases |
| US12410394B2 (en) | 2023-01-06 | 2025-09-09 | Athergen, Inc. | Composition comprising nicotinamide mononucleotide and leucomethylene blue |
| KR20250154422A (ko) | 2023-03-03 | 2025-10-28 | 타우알엑스 쎄라퓨틱스 매니지먼트 리미티드 | 미세혈관 뇌질환 치료를 위한 디아미노페노티아진 |
| CN117447421A (zh) * | 2023-10-30 | 2024-01-26 | 上海沃凯生物技术有限公司 | 一种3,7-双-（二甲胺基）-吩噻嗪的合成方法 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE569430A (https=) | 1957-07-17 | |||
| US3641016A (en) * | 1968-02-16 | 1972-02-08 | Egyt Gyogyszervegyeszeti Gyar | Thionine derivatives |
| JPS52105931A (en) * | 1976-03-02 | 1977-09-06 | Mita Industrial Co Ltd | New leuco coloring matters and process for manufacture thereof |
| US4309255A (en) | 1980-09-10 | 1982-01-05 | International Business Machines Corporation | Electrochromic recording paper |
| US4622395A (en) | 1984-10-01 | 1986-11-11 | Minnesota Mining And Manufacturing Company | Phenoxazine and phenothiazine dyes and leuco forms thereof |
| US4647525A (en) | 1984-10-01 | 1987-03-03 | Minnesota Mining And Manufacturing Company | Stabilized leuco phenazine dyes and their use in an imaging system |
| GB8724412D0 (en) | 1987-10-19 | 1987-11-25 | Medical Res Council | Protein |
| US5571666A (en) | 1988-10-28 | 1996-11-05 | Oklahoma Medical Research Foundation | Thiazine dyes used to inactivate HIV in biological fluids |
| CA2011116C (en) * | 1989-03-06 | 1999-11-16 | Murray A. Kaplan | Lyophilized bmy-28142 dihydrochloride for parenteral use |
| US5220009A (en) | 1990-05-03 | 1993-06-15 | Yeda Research And Development Company Limited | Phenothiazinium salts and their use for disinfecting aqueous effluents |
| JPH0725786A (ja) | 1990-05-16 | 1995-01-27 | Univ Rockefeller | アルツハイマー病を伴うアミロイドーシスの治療 |
| EP0600951A4 (en) | 1991-08-01 | 1996-10-30 | Paul H Voorheis | Diagnostic method for alzheimer's disease. |
| WO1993003177A1 (en) | 1991-08-09 | 1993-02-18 | Massachusetts Institute Of Technology | Novel tau/neurofilament protein kinases |
| DE4140192C2 (de) | 1991-12-05 | 1996-02-29 | Alfatec Pharma Gmbh | Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen |
| DK0618968T3 (da) | 1991-12-06 | 2000-04-10 | Max Planck Gesellschaft | Midler til diagnostisering og behandling af Alzheimer's sygdom |
| JPH06289015A (ja) | 1993-03-30 | 1994-10-18 | Sunstar Inc | フェノチアジン系色源体安定化組成物 |
| GB9316727D0 (en) | 1993-08-12 | 1993-09-29 | Inst Of Psychiatry | Models of alzheimers's disease |
| GB9317193D0 (en) | 1993-08-18 | 1993-10-06 | Zeneca Ltd | Method |
| AU708682B2 (en) | 1994-08-08 | 1999-08-12 | Albert Einstein College Of Medicine Of Yeshiva University | Methods for treating and/or preventing Alzheimer's disease using phenothiazines and/or thioxanthenes |
| DE4430091A1 (de) | 1994-08-25 | 1996-02-29 | Bayer Ag | Verwendung von N-substituierten Phenothiazinen |
| GB9506197D0 (en) * | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| US5804601A (en) | 1995-04-10 | 1998-09-08 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamic acid compounds, their production and use |
| US5693638A (en) | 1996-02-23 | 1997-12-02 | Myers; Daniel | Method of treating a migraine headache |
| US6333322B1 (en) | 1996-03-13 | 2001-12-25 | Eisai Co., Ltd. | Nitrogen-containing tricyclic compounds and drugs containing the same |
| WO1998031219A1 (en) | 1997-01-21 | 1998-07-23 | The American National Red Cross | Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light |
| WO1999062548A1 (en) | 1998-06-01 | 1999-12-09 | Advanced Research And Technology Institute | Methods and compositions for diagnosing tauopathies |
| FR2788436A1 (fr) | 1999-01-14 | 2000-07-21 | Pf Medicament | Composition d'un derive de phenothiazine |
| AU2001229619A1 (en) | 2000-01-21 | 2001-07-31 | Pharmacia And Upjohn Company | Transgenic mouse model of human neurodegenerative disease |
| GB0017060D0 (en) | 2000-07-11 | 2000-08-30 | Hunter Fleming Ltd | Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| WO2003000714A2 (en) | 2001-06-22 | 2003-01-03 | Panacea Pharmaceuticals, Inc. | Compositions and methods for preventing protein aggregation in neurodegenerative diseases |
| GB0117326D0 (en) | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
| US7410965B2 (en) | 2002-05-29 | 2008-08-12 | Gruenenthal Gmbh | Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol |
| US6953974B2 (en) * | 2003-08-26 | 2005-10-11 | Texas Instruments Incorporated | EEPROM device and method for providing lower programming voltage |
| GB0322756D0 (en) | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
| EP1687286A1 (en) | 2003-11-28 | 2006-08-09 | Photopharmica Limited | Developments in biologically active methylene blue derivatives (2) |
| CN101084204B (zh) | 2004-09-23 | 2012-12-05 | 卫思道制药有限公司 | 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法 |
| SI2322517T1 (sl) | 2004-09-23 | 2019-06-28 | Wista Laboratories Ltd. | Postopki za kemijsko sintezo in čiščenje diaminofenotiazinijevih spojin, vključno metiltioninijevega klorida (MTC) |
| WO2007056439A1 (en) | 2005-11-08 | 2007-05-18 | Collegium Pharmaceutical, Inc. | Salts of methylene blue and its derivatives |
| SI2004155T1 (en) | 2006-03-29 | 2018-05-31 | Wista Laboratories Ltd. | Inhibitors of protein aggregation |
| WO2007110630A1 (en) | 2006-03-29 | 2007-10-04 | Wista Laboratories Ltd. | Thioninium compounds and their use |
| ES2349322T7 (es) | 2006-03-29 | 2019-10-17 | Wista Lab Ltd | Sales de 3,7-diamino-10H-fenotiazina y su utilización |
| MY148145A (en) | 2006-07-11 | 2013-03-15 | Wista Lab Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| AU2008265045B2 (en) | 2007-06-19 | 2014-02-27 | Taurx Therapeutics Management Ltd. | Phenothiazine compounds for treating Mild Cognitive Impairment |
| CA2701075C (en) | 2007-10-03 | 2019-02-12 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines. |
| JP5898701B2 (ja) | 2011-02-11 | 2016-04-13 | ウィスタ ラボラトリーズ リミテッド | フェノチアジンジアミニウム塩およびそれらの使用 |
| GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| JP7317787B2 (ja) | 2020-10-19 | 2023-07-31 | トヨタ自動車株式会社 | 排ガス浄化装置 |
-
2007
- 2007-03-28 ES ES07732164T patent/ES2349322T7/es active Active
- 2007-03-28 US US12/294,599 patent/US7888350B2/en active Active
- 2007-03-28 HR HRP20100614TT patent/HRP20100614T4/hr unknown
- 2007-03-28 AT AT07732164T patent/ATE478058T3/de unknown
- 2007-03-28 CA CA2646163A patent/CA2646163C/en active Active
- 2007-03-28 CN CN200780020349.XA patent/CN101460472B/zh active Active
- 2007-03-28 MY MYPI20083821A patent/MY143757A/en unknown
- 2007-03-28 EP EP07732164.4A patent/EP2013191B3/en active Active
- 2007-03-28 CN CN201410269784.8A patent/CN104119294B/zh active Active
- 2007-03-28 PT PT07732164T patent/PT2013191E/pt unknown
- 2007-03-28 CN CN201811196758.1A patent/CN109384741B/zh active Active
- 2007-03-28 KR KR1020087026537A patent/KR100983301B1/ko active Active
- 2007-03-28 DK DK07732164.4T patent/DK2013191T6/en active
- 2007-03-28 EA EA200870384A patent/EA014552B1/ru unknown
- 2007-03-28 CN CN201510002365.2A patent/CN104606199B/zh active Active
- 2007-03-28 CN CN201510002371.8A patent/CN104529939B/zh active Active
- 2007-03-28 JP JP2009502205A patent/JP5520043B2/ja active Active
- 2007-03-28 DE DE602007008550T patent/DE602007008550D1/de active Active
- 2007-03-28 AU AU2007231124A patent/AU2007231124B2/en active Active
- 2007-03-28 WO PCT/GB2007/001103 patent/WO2007110627A2/en not_active Ceased
- 2007-03-28 PL PL07732164T patent/PL2013191T6/pl unknown
-
2008
- 2008-10-02 IL IL194516A patent/IL194516A/en active IP Right Grant
-
2013
- 2013-02-14 JP JP2013026635A patent/JP5814957B2/ja active Active
- 2013-11-14 JP JP2013236080A patent/JP2014055165A/ja active Pending
-
2014
- 2014-04-03 IL IL231890A patent/IL231890A/en active IP Right Grant
-
2015
- 2015-10-30 US US14/929,111 patent/US11344558B2/en active Active
-
2022
- 2022-02-02 US US17/591,306 patent/US11951110B2/en active Active
-
2024
- 2024-03-05 US US18/595,985 patent/US12324810B2/en active Active
-
2025
- 2025-05-02 US US19/197,925 patent/US20250325557A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009531403A5 (https=) | ||
| CA2646163A1 (en) | 3,7-diamino-10h-phenothiazine salts and their use | |
| US10358428B2 (en) | Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof | |
| JP2021100937A5 (https=) | ||
| JP2019524883A5 (https=) | ||
| JP2005523922A5 (https=) | ||
| JP2019537599A5 (https=) | ||
| JP2020534263A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2017537158A5 (https=) | ||
| JP2009531376A5 (https=) | ||
| JP2012522847A5 (https=) | ||
| JP2017523225A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| JP2007524683A5 (https=) | ||
| JP2007502777A5 (https=) | ||
| JP2019504890A5 (https=) | ||
| BRPI0815057B1 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| JP2020529994A5 (https=) | ||
| BR122019022628B1 (pt) | forma b de di-hidrato de cloreto de metiltionínio, seu processo de preparação, e composição farmacêutica | |
| JP2018531987A5 (https=) | ||
| JP2005508337A5 (https=) | ||
| JP2018520147A5 (https=) | ||
| JP2020128426A5 (https=) | ||
| JP2010527985A5 (https=) |